LY2801653

LY2801653
Item number Size Datasheet Manual SDS Delivery time Quantity Price
SYN-1222-M001 1 mg -

3 - 9 business days*

106.00€
SYN-1222-M005 5 mg -

3 - 9 business days*

237.00€
SYN-1222-M010 10 mg -

3 - 9 business days*

355.00€
SYN-1222-M050 50 mg -

3 - 9 business days*

-
SYN-1222-M100 100 mg -

3 - 9 business days*

-
 
Solid. Soluble in DMSO. LY2801653 is an orally bioavailable multi-kinase inhibitor with potent... more
Product information "LY2801653"
Solid. Soluble in DMSO. LY2801653 is an orally bioavailable multi-kinase inhibitor with potent activity against MET, MST1R and other oncoproteins. It displays anti-tumour activities in mouse xenograft models. In vitro, LY2801653 has an IC50 for inhibition of MET phosphorylation between 35.2-59.2nM. LY2801653 was found in nonclinical models to also have potent activity against several other receptor tyrosine oncokinases including FLT3, AXL, MERTK, TEK, ROS1, DDR1/2 and against the serine/threonine kinases MKNK1/2.
Keywords: LY-2801653, N-(3-Fluoro-4-((1-methyl-6-(1H-pyrazol-4-yl)-1H-indazol-5-yl)oxy)phenyl)-1-(4-fluorophenyl)-6-methyl-2-oxo-1,2-dihydropyridine-3-carboxamide
Supplier: SYNkinase
Supplier-Nr: 1222

Properties

Application: Multi-kinase inhibitor
MW: 552,5 D
Formula: C30H22F2N6O3
Purity: >95%
Format: Solid

Database Information

CAS : 1206799-15-6| Matching products

Handling & Safety

Storage: +4°C
Shipping: +20°C (International: +20°C)
GHS Hazard Pictograms:
H Phrases: H302, H317, H332
Caution
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow. more
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "LY2801653"
Write a review
or to review a product.
Viewed